Fatal invasive pulmonary aspergillosis associated with adalimumab therapy.
Manz
M
M
Beglinger
C
C
Vavricka
S R
SR
D000068879:Adalimumab; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000188:drug therapy; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D055744:Invasive Pulmonary Aspergillosis / Q000139:chemically induced*; D009894:Opportunistic Infections / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab